Literature DB >> 7788981

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.

M Tanaka1, K Tanaka, O Onodera, S Tsuji.   

Abstract

Passive transfer of anti-Yo antibody from patients with paraneoplastic cerebellar degeneration (PCD) associated with gynecological or breast carcinoma has not been successful in inducing an animal model. We used active immunization with recombinant Yo protein of four strains of mice bearing different MHC molecules: BALB/c (H-2d), C3H (H-2k), C57BL/6 (H-2b), SJL/J (H-2s). All the strains produced high anti-Yo antibody titer but none developed cerebellar ataxia or showed Purkinje cell loss. Spleen cells from the immunized mice also reacted with recombinant protein. Because C57BL/6(nu/nu) mice produce no anti-Yo antibody, mature helper T cells are required for its production. Results suggest that antibody production in peripheral blood alone is not sufficient for the development of PCD and that MHC class II molecules function in the activation of T cells to help B cells to help B cells produce antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788981     DOI: 10.1016/0303-8467(95)00005-5

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  17 in total

Review 1.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 2.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

3.  CD4+ and CD8+ T cells are both needed to induce paraneoplastic neurological disease in a mouse model.

Authors:  Christina Gebauer; Béatrice Pignolet; Lidia Yshii; Emilie Mauré; Jan Bauer; Roland Liblau
Journal:  Oncoimmunology       Date:  2016-12-09       Impact factor: 8.110

4.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

5.  [Pathophysiology of antibody-associated diseases of the central nervous system].

Authors:  C G Bien; J Bauer
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

6.  Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.

Authors:  Duncan H Whitney; Michael R Elashoff; Kate Porta-Smith; Adam C Gower; Anil Vachani; J Scott Ferguson; Gerard A Silvestri; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  BMC Med Genomics       Date:  2015-05-06       Impact factor: 3.063

Review 7.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

8.  T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

Authors:  Nathalie E Blachère; Dana E Orange; Bianca D Santomasso; Jessica Doerner; Patricia K Foo; Margaret Herre; John Fak; Sébastien Monette; Emily C Gantman; Mayu O Frank; Robert B Darnell
Journal:  Eur J Immunol       Date:  2014-11       Impact factor: 5.532

Review 9.  Cell-mediated immune responses in paraneoplastic neurological syndromes.

Authors:  Mikolaj Piotr Zaborowski; Slawomir Michalak
Journal:  Clin Dev Immunol       Date:  2013-12-30

Review 10.  Paraneoplastic neurological syndromes associated with ovarian tumors.

Authors:  Mikolaj Piotr Zaborowski; Marek Spaczynski; Ewa Nowak-Markwitz; Slawomir Michalak
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-26       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.